Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181835 | SCV000234138 | pathogenic | not provided | 2012-08-19 | criteria provided, single submitter | clinical testing | p.Gln702Stop (CAG>TAG):c.2104 C>T in exon 8 of the KCNH2 gene (NM_000238.2)The Gln702Stop mutation in the KCNH2 gene has not been reported previously as a disease-causing mutation or as benign polymorphism, to our knowledge. Gln702Stop is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Other nonsense mutations in the KCNH2 gene (Trp705Stop, Gln725Stop) have been reported in association with LQTS. In summary, Gln702Stop in the KCNH2 gene is interpreted to be a disease-causing mutation. The variant is found in LQT panel(s). |
Fulgent Genetics, |
RCV000763170 | SCV000893759 | pathogenic | Short QT syndrome 1; Long QT syndrome 2 | 2018-10-31 | criteria provided, single submitter | clinical testing |